Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 639

Results For "LA"

7128 News Found

U.S. FDA approves Cytalux injection for identifying ovarian cancer during surgery
Drug Approval | November 30, 2021

U.S. FDA approves Cytalux injection for identifying ovarian cancer during surgery

It is the first targeted fluorescent imaging agent that illuminates ovarian cancer intraoperatively, enabling the detection of more cancer for removal


DaVita research indicates effectiveness of mRNA vaccine in dialysis patients
News | November 30, 2021

DaVita research indicates effectiveness of mRNA vaccine in dialysis patients

Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively


RDIF believes that Sputnik vaccines can neutralise Omicron
News | November 30, 2021

RDIF believes that Sputnik vaccines can neutralise Omicron

According to the Russian Direct Investment Fund (RDIF), the Russian Sputnik V and Sputnik Light vaccines have proven to be highly effective against all variants of SARC-Cov-2


Covishield effectiveness during the second wave at 63 per cent
Public Health | November 30, 2021

Covishield effectiveness during the second wave at 63 per cent

Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent


Govt reviews public health preparedness with states/UTs over Omicron
Policy | November 30, 2021

Govt reviews public health preparedness with states/UTs over Omicron

The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases


Thermo Fisher Scientific’s new CRISPR Genome editing protein
Biotech | November 30, 2021

Thermo Fisher Scientific’s new CRISPR Genome editing protein

Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications


Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy
Biotech | November 30, 2021

Daiichi Sankyo initiates Phase 3 trial for Destiny-Breast11 neoadjuvant therapy

Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab


ZenOnco.io raises US $ 1.4 mn in seed funding
Startup | November 29, 2021

ZenOnco.io raises US $ 1.4 mn in seed funding

The funds will be used to scale up existing operations and launch new products


Masimo Rad-G helps identify paediatric pneumonia in India
Medical Device | November 29, 2021

Masimo Rad-G helps identify paediatric pneumonia in India

Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor


Bharat Biotech commences export of Covaxin
News | November 29, 2021

Bharat Biotech commences export of Covaxin

It’s a two-dose vaccine administered 28 days apart